ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,675Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 890

$1.24M Total Retail Price of All Prescriptions

Rank: 23 out of 890

1,015 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 1,015 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

22% of this provider’s 1,015 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 11,379 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,033 434 S3 1 3
AMLODIPINE BESYLATE 630 468 2 1
HYDROCHLOROTHIAZIDE 375 280 3 9
FUROSEMIDE 372 272 4 7
SIMVASTATIN 369 284 5 5
LISINOPRIL 354 241 6 4
TRAMADOL HCL 325 230 7 16
CARVEDILOL 302 205 8 22
METFORMIN HCL 254 150 9 6
OMEPRAZOLE 249 137 10 8
GABAPENTIN 241 165 11 12
NEXIUM 241 160 11 14
ATORVASTATIN CALCIUM 228 170 13 13
METOPROLOL TARTRATE 223 181 14 15
POTASSIUM CHLORIDE 203 161 15 11
METOPROLOL SUCCINATE 188 145 16 17
LEVOTHYROXINE SODIUM 181 137 17 2
CARISOPRODOL 172 0 R 18 69
PRAVASTATIN SODIUM 171 122 19 10
MELOXICAM 167 112 20 18
ZOLPIDEM TARTRATE 166 106 21 19
CLONIDINE HCL 166 117 21 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 159 95 23 21
DIOVAN HCT 157 109 24 48
NAMENDA 144 141 25 36
PROAIR HFA 143 78 26 55
FLUTICASONE PROPIONATE 139 82 27 39
OXYCODONE HCL-ACETAMINOPHEN 139 50 S2 27 127
IBUPROFEN 136 71 29 101
CLOPIDOGREL 135 101 30 28
DONEPEZIL HCL 127 127 31 30
LANTUS 127 90 31 50
CIPROFLOXACIN HCL 127 99 31 58
ALLOPURINOL 127 103 31 31
DIOVAN 120 101 35 33
AZITHROMYCIN 113 65 36 37
ALPRAZOLAM 112 62 37 95
CRESTOR 111 71 38 25
NAPROXEN 110 68 39 84
WARFARIN SODIUM 107 81 40 24
PLAVIX 106 87 41 42
MEGESTROL ACETATE 103 87 R 42 92
LOSARTAN POTASSIUM 102 79 43 29
ONGLYZA 101 80 44 146
OXYCODONE-ACETAMINOPHEN 95 48 S2 45 250
FLUCONAZOLE 94 26 46 155
AMLODIPINE BESYLATE-BENAZEPRIL 93 68 47 41
MIRTAZAPINE 93 60 47 82
ENDOCET 88 22 S2 49 218
GLIPIZIDE 87 60 50 62
DIAZEPAM 85 44 51 278
ADVAIR DISKUS 78 28 52 52
VIAGRA 77 40 53 271
SINGULAIR 76 41 54 79
SPIRONOLACTONE 76 51 54 85
ESCITALOPRAM OXALATE 75 52 56 51
SYMBICORT 75 40 56 174
INSULIN SYRINGE 72 45 58 99
GLIMEPIRIDE 71 50 59 27
PANTOPRAZOLE SODIUM 71 45 59 34
POLYETHYLENE GLYCOL 3350 66 44 61 67
TRIAMTERENE-HCTZ 66 42 61 61
CELEBREX 65 52 63 91
HYDRALAZINE HCL 65 54 63 100
AMOXICILLIN 64 30 65 94
AMITRIPTYLINE HCL 62 35 R 66 43
SPIRIVA 61 39 67 66
TIZANIDINE HCL 61 29 67 106
LOVAZA 60 30 69 120
PROMETHAZINE HCL 60 12 R 69 104
COMBIVENT 60 35 69 144
RANITIDINE HCL 60 51 69 49
DOXEPIN HCL 59 33 73 176
ACETAMINOPHEN-CODEINE 58 43 S3 74 124
JANUVIA 58 43 74 59
METHYLPREDNISOLONE 57 31 76 109
TRAZODONE HCL 56 34 77 40
ALENDRONATE SODIUM 56 56 77 38
LOVASTATIN 54 44 79 46
CLOTRIMAZOLE-BETAMETHASONE 54 37 79 152
TAMSULOSIN HCL 54 37 79 32
PREDNISONE 53 39 82 47
CYCLOBENZAPRINE HCL 52 21 R 83 64
BENAZEPRIL HCL 52 44 83 44
ATENOLOL 51 40 85 23
QUETIAPINE FUMARATE 50 27 86 73
NIFEDICAL XL 50 30 86 253
BUPROPION XL 50 33 86 190
LEVETIRACETAM 50 25 86 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.